Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies

Exploring the Mechanisms Underlying the Cardiotoxic Effects of Immune Checkpoint Inhibitor Therapies

Adaptive immune response modulation has taken a central position in cancer therapy in recent decades. Treatment with immune checkpoint inhibitors (ICIs) is now indicated in many cancer types with exceptional results. The two major inhibitory pathways involved are cytotoxic T-lymphocyte-associated pr...

Full description

Bibliographic Details
Main Authors:	Daniel Ronen, Aseel Bsoul, Michal Lotem, Suzan Abedat, Merav Yarkoni, Offer Amir, Rabea Asleh
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Vaccines
Subjects:	immune checkpoint inhibitors cardiotoxicity lymphocyte immune system mechanisms adverse effects
Online Access:	https://www.mdpi.com/2076-393X/10/4/540

Similar Items

Immune Checkpoint Inhibitors Related to Cardiotoxicity
by: Ru Chen, et al.
Published: (2022-11-01)

Advances in immune checkpoint inhibitors induced-cardiotoxicity
by: Xiang Li, et al.
Published: (2023-02-01)

Immune Checkpoint Inhibitors—Associated Cardiotoxicity
by: Chenghui Li, et al.
Published: (2022-02-01)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
by: Inbar Nardi Agmon, et al.
Published: (2022-02-01)

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01)

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
by: Lu Gan, et al.
Published: (2022-08-01)

Cardiotoxicity induced by immune checkpoint inhibitor: The complete insight into mechanisms, monitoring, diagnosis, and treatment
by: Sridha Ganesh, et al.
Published: (2022-09-01)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
by: Chenxin Chen, et al.
Published: (2021-02-01)

Gender differences in cardiotoxicities associated with immune checkpoint inhibitor therapy in cancer patients
by: Sheharyar Minhas, et al.
Published: (2020-01-01)

Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience
by: Junjuan Xiao, et al.
Published: (2023-04-01)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
by: Nicolas Palaskas, et al.
Published: (2020-01-01)

Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
by: Irene Toribio-García, et al.
Published: (2023-08-01)

Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
by: Jianqing She, et al.
Published: (2022-05-01)

Immune Checkpoint Inhibitors and the Heart
by: Diana Larisa Mocan-Hognogi, et al.
Published: (2021-09-01)

Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management
by: Muhammet Gürdoğan, et al.
Published: (2020-07-01)

Cardiotoxicity of checkpoint inhibitors: focus on immune side effects
by: Yuri I. Buziashvili, et al.
Published: (2024-04-01)

Inflammatory biomarkers in assessing severity and prognosis of immune checkpoint inhibitor‐associated cardiotoxicity
by: Lin Liang, et al.
Published: (2023-06-01)

Immune checkpoint inhibitor-related adverse cardiac events in patients with lung cancer: a systematic review and meta-analysis
by: Xiao-Tong Zhang, et al.
Published: (2022-11-01)

Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
by: Ruiting Li, et al.
Published: (2021-06-01)

Successful immune checkpoint inhibitor rechallenge after immune-related pericarditis: Clinical case series
by: Adrian M. Chye, et al.
Published: (2022-08-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
by: YU Lin, et al.
Published: (2021-08-01)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
by: Yu-Wen Zhou, et al.
Published: (2019-11-01)

An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors
by: Roberta Esposito, et al.
Published: (2021-05-01)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do
by: Concetta Zito, et al.
Published: (2022-11-01)

Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study
by: Danielle Delombaerde, et al.
Published: (2023-04-01)

Dynamic Changes of Serum Heart Type-Fatty Acid Binding Protein in Cancer Patients Treated With Immune Checkpoint Inhibitors
by: Ming Yuan, et al.
Published: (2021-10-01)

Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases
by: Liudmila Zotova
Published: (2023-03-01)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Solid Tumors: Real-World Incidence, Risk Factors, and Prognostic Analysis
by: Xue Chen, et al.
Published: (2022-05-01)

Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but serious adverse event
by: Abdulrazzak Zarifa, et al.
Published: (2018-10-01)

Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer
by: Lova Sun, MD, et al.
Published: (2019-12-01)

Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting
by: Melissa Y.Y. Moey, MD, MSc, et al.
Published: (2020-09-01)

Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
by: Cong Wang, et al.
Published: (2021-12-01)

Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
by: Vincenzo Quagliariello, et al.
Published: (2020-10-01)

Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis
by: Maobai Liu, et al.
Published: (2022-09-01)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
by: Nikhil Agrawal, et al.
Published: (2019-03-01)

Cardiac Complications in Immune Checkpoint Inhibition Therapy
by: Kazuko Tajiri, et al.
Published: (2019-01-01)

ICIs-Related Cardiotoxicity in Different Types of Cancer
by: Mei Dong, et al.
Published: (2022-06-01)

Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
by: Moran Gvili Perelman, et al.
Published: (2024-01-01)

Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach
by: Gillian Murtagh, et al.
Published: (2024-02-01)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
by: María Torrente, et al.
Published: (2022-12-01)